Minerva Neurosciences, Inc.
NERV
$2.39
-$0.045-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -66.38% | -67.31% | -4.16% | -54.19% | 104.53% |
| Gross Profit | 66.38% | 67.31% | 4.16% | 54.19% | -104.53% |
| SG&A Expenses | -14.11% | 1.02% | 3.59% | -5.95% | -8.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -46.25% | -41.59% | -36.95% | -28.17% | 38.88% |
| Operating Income | 46.25% | 41.59% | 36.95% | 28.17% | -38.88% |
| Income Before Tax | 60.42% | 56.20% | 52.65% | 387.88% | -32.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 60.42% | 56.20% | 52.65% | 387.88% | -32.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.42% | 56.20% | 52.65% | 387.88% | -32.97% |
| EBIT | 46.25% | 41.59% | 36.95% | 28.17% | -38.88% |
| EBITDA | 46.26% | 41.60% | 36.95% | 28.18% | -38.90% |
| EPS Basic | 60.42% | 56.21% | 52.65% | 387.88% | 3.18% |
| Normalized Basic EPS | 60.42% | 56.20% | 52.64% | 387.86% | 3.18% |
| EPS Diluted | 60.42% | 56.21% | 52.69% | 387.46% | 3.18% |
| Normalized Diluted EPS | 60.42% | 56.20% | 52.64% | 387.86% | 3.18% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 37.34% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 37.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |